Timothy Henrich, MD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave
San Francisco CA 94110
Phone628-206-5518
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Yale UniversityM.D.2004School of Medicine
    Harvard UniversityM.M.Sc.2013School of Medicine
    Oberlin CollegeB.A.1996
    Brigham and Women's HospitalInternal Medicine Residency2007
    Massachusetts General Hospital and Brigham and Women's HospitalInfectious Disease Fellowship2009

    Collapse Overview 
    Collapse Overview
    My laboratory/research group specializes in immunmodulatory, cytoreductive chemotherapeutic and stem cell transplantation approaches to HIV-1 cure. We are also involved in the design and implementation of novel nano/microtechnologies and PET-based imaging approaches to characterize viral reservoirs.

    Collapse Research 
    Collapse Research Activities and Funding
    In Vivo PET Imaging of HIV Infection
    NIH R01AI152932Aug 12, 2020 - Jul 31, 2025
    Role: Principal Investigator
    Targeting Non Viral Markers of HIV Persistence
    NIH R01AI141003May 15, 2018 - Apr 30, 2023
    Role: Principal Investigator
    Biomarkers of CNS HIV Persistence
    NIH R21MH116716Mar 1, 2018 - Jan 31, 2021
    Role: Principal Investigator
    Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin
    NIH R33AI116205Sep 1, 2016 - Aug 31, 2021
    Role: Principal Investigator
    Single Cell Characterization of Latent HIV-1 Reservoirs
    NIH R01AI122862Aug 2, 2016 - Jul 31, 2021
    Role: Principal Investigator
    Measurement of Antibody Epitope Signatures by Peptide Microarrays to Determine Recency of HIV Infection
    NIH R21AI122938Jun 24, 2016 - May 31, 2019
    Role: Co-Principal Investigator
    Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin
    NIH R21AI116205Sep 1, 2014 - Aug 31, 2016
    Role: Principal Investigator
    A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs
    NIH R21AI113117Jul 1, 2014 - Jun 30, 2017
    Role: Principal Investigator
    Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells
    NIH R21AI110277Jun 1, 2014 - May 31, 2017
    Role: Principal Investigator
    Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics
    NIH K23AI098480Mar 1, 2012 - Feb 28, 2017
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. TNF-α inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines. AIDS. 2021 11 01; 35(13):2163-2168. Claytor JD, Viramontes O, Conner S, Wen KW, Beck K, Chin-Hong PV, Henrich TJ, Peluso MJ. PMID: 34115645.
      View in: PubMed   Mentions:    Fields:    
    2. SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency. medRxiv. 2021 Sep 14. Takahashi S, Peluso MJ, Hakim J, Turcios K, Janson O, Routledge I, Busch MP, Hoh R, Tai V, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Greenhouse B, Rodríguez-Barraquer I. PMID: 34545373.
      View in: PubMed   Mentions:
    3. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518. Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. PMID: 34358460.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    4. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. Sci Adv. 2021 Jul; 7(31). Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Donatelli J, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J, Trinh L, Wrin T, Petropoulos CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. PMID: 34330709.
      View in: PubMed   Mentions: 8     Fields:    
    5. Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease. Open Forum Infect Dis. 2021 Aug; 8(8):ofab393. Peluso MJ, Munter SE, Lynch KL, Yun C, Torres L, Iyer NS, Donatelli J, Ryan L, Deitchman AN, Deeks SG, Rutishauser RL, Henrich TJ. PMID: 34395717.
      View in: PubMed   Mentions:
    6. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients. J Clin Invest. 2021 07 15; 131(14). Stock PG, Henrich TJ, Segev DL, Werbel WA. PMID: 34143755.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    7. Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records. Nat Commun. 2021 06 11; 12(1):3566. Routledge I, Epstein A, Takahashi S, Janson O, Hakim J, Duarte E, Turcios K, Vinden J, Sujishi K, Rangel J, Coh M, Besana L, Ho WK, Oon CY, Ong CM, Yun C, Lynch K, Wu AHB, Wu W, Karlon W, Thornborrow E, Peluso MJ, Henrich TJ, Pak JE, Briggs J, Greenhouse B, Rodriguez-Barraquer I. PMID: 34117227.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    8. multiSero: open multiplex-ELISA platform for analyzing antibody responses to SARS-CoV-2 infection. medRxiv. 2021 May 11. Byrum JR, Waltari E, Janson O, Guo SM, Folkesson J, Chhun BB, Vinden J, Ivanov IE, Forst ML, Li H, Larson AG, Wu W, Tato CM, McCutcheon KM, Peluso MJ, Henrich TJ, Deeks SG, Prakash M, Greenhouse B, Pak JE, Mehta SB. PMID: 34013298.
      View in: PubMed   Mentions:
    9. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. Lancet HIV. 2021 06; 8(6):e334-e341. Spinelli MA, Lynch KL, Yun C, Glidden DV, Peluso MJ, Henrich TJ, Gandhi M, Brown LB. PMID: 33933189.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    10. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection. Nat Biotechnol. 2021 08; 39(8):928-935. Elledge SK, Zhou XX, Byrnes JR, Martinko AJ, Lui I, Pance K, Lim SA, Glasgow JE, Glasgow AA, Turcios K, Iyer NS, Torres L, Peluso MJ, Henrich TJ, Wang TT, Tato CM, Leung KK, Greenhouse B, Wells JA. PMID: 33767397.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    11. Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study. medRxiv. 2021 Mar 24. Santiago-Rodriguez EI, Maiorana A, Peluso MJ, Hoh R, Tai V, Fehrman EA, Hernandez Y, Torres L, Spinelli MA, Gandhi M, Kelly JD, Martin JN, Henrich TJ, Deeks SG, Sauceda JA. PMID: 33758881.
      View in: PubMed   Mentions:
    12. Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. medRxiv. 2021 Mar 12. Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, Tai V, Fehrman EA, Torres L, Hernandez Y, Williams MC, Arreguin MI, Bautista JA, Ngo LH, Deswal M, Munter SE, Martinez EO, Anglin KA, Romero MD, Tavs J, Rugart PR, Chen JY, Sans HM, Murray VW, Ellis PK, Donohue KC, Massachi JA, Weiss JO, Mehdi I, Pineda-Ramirez J, Tang AF, Wenger M, Assenzio M, Yuan Y, Krone M, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Sauceda JA, Gandhi M, Hsue PY, Henrich TJ, Deeks SG, Martin JN. PMID: 33758895.
      View in: PubMed   Mentions:
    13. SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay. medRxiv. 2021 Mar 05. Peluso MJ, Takahashi S, Hakim J, Kelly JD, Torres L, Iyer NS, Turcios K, Janson O, Munter SE, Thanh C, Nixon CC, Hoh R, Tai V, Fehrman EA, Hernandez Y, Spinelli MA, Gandhi M, Palafox MA, Vallari A, Rodgers MA, Prostko J, Hackett J, Trinh L, Wrin T, Petroplolous CJ, Chiu CY, Norris PJ, DiGermanio C, Stone M, Busch MP, Elledge SK, Zhou XX, Wells JA, Shu A, Kurtz TW, Pak JE, Wu W, Burbelo PD, Cohen JI, Rutishauser RL, Martin JN, Deeks SG, Henrich TJ, Rodriguez-Barraquer I, Greenhouse B. PMID: 33688675.
      View in: PubMed   Mentions:
    14. Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19. medRxiv. 2021 Mar 01. Peluso MJ, Deitchman AN, Torres L, Iyer NS, Nixon CC, Munter SE, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman E, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. PMID: 33688685.
      View in: PubMed   Mentions:
    15. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells. 2021 02 13; 10(2). Sun B, Tang N, Peluso MJ, Iyer NS, Torres L, Donatelli JL, Munter SE, Nixon CC, Rutishauser RL, Rodriguez-Barraquer I, Greenhouse B, Kelly JD, Martin JN, Deeks SG, Henrich TJ, Pulliam L. PMID: 33668514.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    16. Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco. Res Sq. 2021 Feb 04. Routledge I, Epstein A, Takahashi S, Janson O, Hakim J, Duarte E, Turcios K, Vinden J, Sujishi K, Rangel J, Coh M, Besana L, Ho WK, Oon CY, Ong CM, Yun C, Lynch K, Wu AHB, Wu W, Karlon W, Thornborrow E, Peluso MJ, Henrich TJ, Pak JE, Briggs J, Greenhouse B, Rodriguez-Barraquer I. PMID: 33564754.
      View in: PubMed   Mentions:
    17. Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo. J Virol. 2021 Feb 03. Gramatica A, Schwarzer R, Brantley W, Varco-Merth B, Sperber HS, Hull PA, Montano M, Migueles SA, Rosenthal D, Hogan LE, Johnson JR, Packard TA, Grimmett ZW, Herzig E, Besnard E, Nekorchuk M, Hsiao F, Deeks SG, Snape M, Kiernan B, Roan NR, Lifson JD, Estes JD, Picker LJ, Verdin E, Krogan NJ, Henrich TJ, Connors M, Ott M, Pillai SK, Okoye AA, Greene WC. PMID: 33536176.
      View in: PubMed   Mentions: 1     Fields:    
    18. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J Neurovirol. 2021 02; 27(1):191-195. Hellmuth J, Barnett TA, Asken BM, Kelly JD, Torres L, Stephens ML, Greenhouse B, Martin JN, Chow FC, Deeks SG, Greene M, Miller BL, Annan W, Henrich TJ, Peluso MJ. PMID: 33528824.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    19. Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. J Leukoc Biol. 2021 07; 110(1):21-26. Corley MJ, Pang APS, Dody K, Mudd PA, Patterson BK, Seethamraju H, Bram Y, Peluso MJ, Torres L, Iyer NS, Premeaux TA, Yeung ST, Chandar V, Borczuk A, Schwartz RE, Henrich TJ, Deeks SG, Sacha JB, Ndhlovu LC. PMID: 33464637.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    20. 969. TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines. Open Forum Infectious Diseases. 2020 Dec 31; 7(Supplement_1):s514-s514. Claytor CJ, Viramontes VO, Conner CS, Wen WK, Beck BK, Henrich HT, Chin-Hong CP, Chin-Hong CP, Peluso PM. .
      View in: Publisher Site   Mentions:
    21. Treatment of immunocompromised COVID-19 patients with convalescent plasma. Transpl Infect Dis. 2021 Apr; 23(2):e13477. Fung M, Nambiar A, Pandey S, Aldrich JM, Teraoka J, Freise C, Roberts J, Chandran S, Hays SR, Bainbridge E, DeVoe C, Roque Gardner A, Yokoe D, Henrich TJ, Babik JM, Chin-Hong P. PMID: 32989856.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    22. A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19. Clin Infect Dis. 2020 Nov 19. Peluso MJ, Bakkour S, Busch MP, Deeks SG, Henrich TJ. PMID: 33211091.
      View in: PubMed   Mentions: 1     Fields:    
    23. Total-Body PET Imaging in Infectious Diseases. PET Clin. 2021 Jan; 16(1):89-97. Henrich TJ, Jones T, Beckford-Vera D, Price PM, VanBrocklin HF. PMID: 33160926.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. A “false-positive” HIV test?. . 2020 Nov 1; 37-44. Peluso PM, Henrich HT. .
      View in: Publisher Site   Mentions:
    25. Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community. Open Forum Infectious Diseases. 2020 Oct 30. Appa AA, Takahashi TS, Rodriguez-Barraquer RI, Chamie CG, Sawyer SA, Duarte DE, Hakim HJ, Turcios TK, Vinden VJ, Janson JO, Manglik MA, Peluso PM, Deeks DS, Henrich HT, Torres TL, Rodgers RM, Hackett HJ, Chiu CC, Havlir HD, Greenhouse GB. .
      View in: Publisher Site   Mentions:
    26. Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa531. Appa A, Takahashi S, Rodriguez-Barraquer I, Chamie G, Sawyer A, Duarte E, Hakim J, Turcios K, Vinden J, Janson O, Manglik A, Peluso MJ, Deeks SG, Henrich TJ, Torres L, Rodgers M, Hackett J, Chiu C, Havlir D, Greenhouse B. PMID: 34109255.
      View in: PubMed   Mentions:
    27. Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study. Am J Transplant. 2021 05; 21(5):1765-1779. Henrich TJ, Schreiner C, Cameron C, Hogan LE, Richardson B, Rutishauser RL, Deitchman AN, Chu S, Rogers R, Thanh C, Gibson EA, Zarinsefat A, Bakkour S, Aweeka F, Busch MP, Liegler T, Baker C, Milush J, Deeks SG, Stock PG. PMID: 32780519.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    28. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection. medRxiv. 2020 Aug 21. Elledge SK, Zhou XX, Byrnes JR, Martinko AJ, Lui I, Pance K, Lim SA, Glasgow JE, Glasgow AA, Turcios K, Iyer N, Torres L, Peluso MJ, Henrich TJ, Wang TT, Tato CM, Leung KK, Greenhouse B, Wells JA. PMID: 32839788.
      View in: PubMed   Mentions:
    29. Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community. medRxiv. 2020 Aug 17. Appa A, Takahashi S, Rodriguez-Barraquer I, Chamie G, Sawyer A, Consortium C, Duarte E, Hakim J, Turcios K, Vinden J, Janson O, Manglik A, Peluso MJ, Deeks SG, Henrich TJ, Torres L, Rodgers M, Hackett J, Chiu C, Havlir D, Greenhouse B. PMID: 32839781.
      View in: PubMed   Mentions:
    30. From Berlin to London: HIV-1 Reservoir Reduction Following Stem Cell Transplantation. Curr HIV/AIDS Rep. 2020 08; 17(4):385-393. Prator CA, Donatelli J, Henrich TJ. PMID: 32519184.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    31. Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States. Am J Transplant. 2020 11; 20(11):3225-3233. Fung M, Chiu CY, DeVoe C, Doernberg SB, Schwartz BS, Langelier C, Henrich TJ, Yokoe D, Davis J, Hays SR, Chandran S, Kukreja J, Ng D, Prostko J, Taylor R, Reyes K, Bainbridge E, Bond A, Chin-Hong P, Babik JM. PMID: 32476258.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    32. Outcomes of immunomodulatory and biologic therapy in people living with HIV. AIDS. 2020 07 01; 34(8):1171-1179. Peluso MJ, Chen J, Munter S, Reed A, Teraoka J, Eshun-Wilson I, Henrich TJ, Chin-Hong PV. PMID: 32310901.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    33. Biosensing: Tunable Fano-Resonant Metasurfaces on a Disposable Plastic-Template for Multimodal and Multiplex Biosensing (Adv. Mater. 19/2020). Advanced Materials. 2020 May 1; 32(19):2070151. Ahmed AR, Ozen OM, Karaaslan KM, Prator PC, Thanh TC, Kumar KS, Torres TL, Iyer IN, Munter MS, Southern SS, Henrich HT, Inci IF, Demirci DU. .
      View in: Publisher Site   Mentions:
    34. Tunable Fano-Resonant Metasurfaces on a Disposable Plastic-Template for Multimodal and Multiplex Biosensing. Adv Mater. 2020 May; 32(19):e1907160. Ahmed R, Ozen MO, Karaaslan MG, Prator CA, Thanh C, Kumar S, Torres L, Iyer N, Munter S, Southern S, Henrich TJ, Inci F, Demirci U. PMID: 32201997.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    35. Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment Interruption. J Infect Dis. 2020 03 16; 221(7):1146-1155. Prator CA, Thanh C, Kumar S, Pan T, Peluso MJ, Bosch R, Jones N, Milush JM, Bakkour S, Stone M, Busch MP, Deeks SG, Hunt PW, Henrich TJ. PMID: 31677350.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    36. Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. JCI Insight. 2020 02 27; 5(4). Peluso MJ, Bacchetti P, Ritter KD, Beg S, Lai J, Martin JN, Hunt PW, Henrich TJ, Siliciano JD, Siliciano RF, Laird GM, Deeks SG. PMID: 32045386.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    37. Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1. J Virus Erad. 2020 Feb 20; 6(1):19-26. Peluso MJ, Thanh C, Prator CA, Hogan LE, Arechiga VM, Stephenson S, Norris PJ, Di Germanio C, Fuchs D, Zetterberg H, Deeks SG, Gisslén M, Price RW, Henrich TJ. PMID: 32175087.
      View in: PubMed   Mentions:
    38. HIV-1 Coreceptor Usage and Variable Loop Contact Impact V3 Loop Broadly Neutralizing Antibody Susceptibility. J Virol. 2020 01 06; 94(2). Registre L, Moreau Y, Ataca ST, Pulukuri S, Henrich TJ, Lin N, Sagar M. PMID: 31694950.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    39. Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS. AIDS. 2019 12 01; 33 Suppl 2:S107-S111. Winston A, Antinori A, Cinque P, Fox HS, Gisslen M, Henrich TJ, Letendre S, Persaud D, Price RW, Spudich S. PMID: 31790376.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    40. OP 3.1 Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. Journal of virus eradication. 2019 Dec 1; 5:23. Peluso PM, Bacchetti BP, Ritter RK, Beg BS, Hunt HP, Henrich HT, Siliciano SJ, Siliciano SR, Laird LG, Deeks DS. .
      View in: Publisher Site   Mentions:
    41. OP 4.2 Characterising ‘exceptional’ control among HIV elite controllers. Journal of virus eradication. 2019 Dec 1; 5:31. Peluso PM, Burbelo BP, Kumar KS, Munter MS, Hoh HR, Lee LS, Hunt HP, Rutishauser RR, Henrich HT, Deeks DS. .
      View in: Publisher Site   Mentions:
    42. Rapid development of HIV elite control in a patient with acute infection. BMC Infect Dis. 2019 Sep 18; 19(1):815. Morley D, Lambert JS, Hogan LE, De Gascun C, Redmond N, Rutishauser RL, Thanh C, Gibson EA, Hobbs K, Bakkour S, Busch MP, Farrell J, McGetrick P, Henrich TJ. PMID: 31533639.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    43. Seeing Is Believing: Nuclear Imaging of HIV Persistence. Front Immunol. 2019; 10:2077. Henrich TJ, Hsue PY, VanBrocklin H. PMID: 31572355.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    44. CD32-RNA Co-localizes with HIV-RNA in CD3+ Cells Found within Gut Tissues from Viremic and ART-Suppressed Individuals. Pathog Immun. 2019; 4(1):147-160. Vásquez JJ, Aguilar-Rodriguez BL, Rodriguez L, Hogan LE, Somsouk M, McCune JM, Deeks SG, Laszik ZG, Hunt PW, Henrich TJ. PMID: 31139759.
      View in: PubMed   Mentions:
    45. Second example reported of a stem-cell transplant in the clinic leading to HIV remission. Nature. 2019 04; 568(7751):175-176. Henrich TJ. PMID: 30962552.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    46. Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphoma. Blood Adv. 2018 12 11; 2(23):3479-3482. Wang CC, Thanh C, Gibson EA, Ball-Burack M, Hogan LE, Descours B, Jones N, Carvidi AB, Munter S, Bakkour S, Busch MP, Milush JM, Deeks SG, Henrich TJ. PMID: 30530753.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    47. Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection. Ann Oncol. 2018 10 01; 29(10):2141-2142. Scully EP, Rutishauser RL, Simoneau CR, Delagrèverie H, Euler Z, Thanh C, Li JZ, Hartig H, Bakkour S, Busch M, Alter G, Marty FM, Wang CC, Deeks SG, Lorch J, Henrich TJ. PMID: 30032204.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    48. Progress towards obtaining an HIV cure: slow but sure. Curr Opin HIV AIDS. 2018 09; 13(5):381-382. Henrich TJ, Lelièvre JD. PMID: 29965799.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    49. NK-cell activation is associated with increased HIV transcriptional activity following allogeneic hematopoietic cell transplantation. Blood Adv. 2018 06 26; 2(12):1412-1416. Hogan LE, Körner C, Hobbs K, Simoneau CR, Thanh C, Gibson EA, Palmer CD, Pandit A, Marty FM, Kuritzkes DR, Jost S, Ritz J, Henrich TJ. PMID: 29921650.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    50. Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation. PLoS One. 2018; 13(5):e0197298. Hogan LE, Hanhauser E, Hobbs KS, Palmer CD, Robles Y, Jost S, LaCasce AS, Abramson J, Hamdan A, Marty FM, Kuritzkes DR, Henrich TJ. PMID: 29746555.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    51. Dolutegravir intensification and HIV persistence: 3 + 1 = 3. Lancet HIV. 2018 05; 5(5):e201-e202. Henrich TJ. PMID: 29643012.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. PLoS Pathog. 2018 02; 14(2):e1006856. Hogan LE, Vasquez J, Hobbs KS, Hanhauser E, Aguilar-Rodriguez B, Hussien R, Thanh C, Gibson EA, Carvidi AB, Smith LCB, Khan S, Trapecar M, Sanjabi S, Somsouk M, Stoddart CA, Kuritzkes DR, Deeks SG, Henrich TJ. PMID: 29470552.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    53. Elucidating the Burden of HIV in Tissues Using Multiplexed Immunofluorescence and In Situ Hybridization: Methods for the Single-Cell Phenotypic Characterization of Cells Harboring HIV In Situ. J Histochem Cytochem. 2018 06; 66(6):427-446. Vasquez JJ, Hussien R, Aguilar-Rodriguez B, Junger H, Dobi D, Henrich TJ, Thanh C, Gibson E, Hogan LE, McCune J, Hunt PW, Stoddart CA, Laszik ZG. PMID: 29462571.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    54. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med. 2017 Nov; 14(11):e1002417. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. PMID: 29112956.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCellsPHPublic Health
    55. Human Immunodeficiency Virus Type 1 Persistence Following Systemic Chemotherapy for Malignancy. J Infect Dis. 2017 07 15; 216(2):254-262. Henrich TJ, Hobbs KS, Hanhauser E, Scully E, Hogan LE, Robles YP, Leadabrand KS, Marty FM, Palmer CD, Jost S, Körner C, Li JZ, Gandhi RT, Hamdan A, Abramson J, LaCasce AS, Kuritzkes DR. PMID: 28838149.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    56. Correction: Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV. PLoS Pathog. 2017 Jul; 13(7):e1006488. Hill AL, Rosenbloom DIS, Goldstein E, Hanhauser E, Kuritzkes DR, Siliciano RF, Henrich TJ. PMID: 28683094.
      View in: PubMed   Mentions:    Fields:    
    57. High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay. EBioMedicine. 2017 Jun; 20:217-229. Yucha RW, Hobbs KS, Hanhauser E, Hogan LE, Nieves W, Ozen MO, Inci F, York V, Gibson EA, Thanh C, Shafiee H, El Assal R, Kiselinova M, Robles YP, Bae H, Leadabrand KS, Wang S, Deeks SG, Kuritzkes DR, Demirci U, Henrich TJ. PMID: 28529033.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    58. A humanized mouse-based HIV-1 viral outgrowth assay with higher sensitivity than in vitro qVOA in detecting latently infected cells from individuals on ART with undetectable viral loads. Virology. 2017 07; 507:135-139. Charlins P, Schmitt K, Remling-Mulder L, Hogan LE, Hanhauser E, Hobbs KS, Hecht F, Deeks SG, Henrich TJ, Akkina R. PMID: 28432928.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    59. Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies. J Infect Dis. 2017 03 15; 215(suppl_3):S134-S141. Henrich TJ, Deeks SG, Pillai SK. PMID: 28520968.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    60. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat Med. 2016 08; 22(8):839-50. Deeks SG, Lewin SR, Ross AL, Ananworanich J, Benkirane M, Cannon P, Chomont N, Douek D, Lifson JD, Lo YR, Kuritzkes D, Margolis D, Mellors J, Persaud D, Tucker JD, Barre-Sinoussi F, International AIDS Society Towards a Cure Working Group , Alter G, Auerbach J, Autran B, Barouch DH, Behrens G, Cavazzana M, Chen Z, Cohen ÉA, Corbelli GM, Eholié S, Eyal N, Fidler S, Garcia L, Grossman C, Henderson G, Henrich TJ, Jefferys R, Kiem HP, McCune J, Moodley K, Newman PA, Nijhuis M, Nsubuga MS, Ott M, Palmer S, Richman D, Saez-Cirion A, Sharp M, Siliciano J, Silvestri G, Singh J, Spire B, Taylor J, Tolstrup M, Valente S, van Lunzen J, Walensky R, Wilson I, Zack J. PMID: 27400264.
      View in: PubMed   Mentions: 193     Fields:    Translation:Humans
    61. INTERACTIVE MEDICAL CASE. A Woman with Dyspnea and Altered Mental Status. N Engl J Med. 2016 Jun 09; 374(23):e29. Patel KP, Vaidya A, Gibson CJ, Henrich TJ, Lyons JL. PMID: 27276581.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring. Adv Drug Deliv Rev. 2016 08 01; 103:90-104. Lifson MA, Ozen MO, Inci F, Wang S, Inan H, Baday M, Henrich TJ, Demirci U. PMID: 27262924.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    63. Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV. PLoS Pathog. 2016 04; 12(4):e1005535. Hill AL, Rosenbloom DI, Goldstein E, Hanhauser E, Kuritzkes DR, Siliciano RF, Henrich TJ. PMID: 27119536.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    64. Evolution of coreceptor utilization to escape CCR5 antagonist therapy. Virology. 2016 07; 494:198-214. Zhang J, Gao X, Martin J, Rosa B, Chen Z, Mitreva M, Henrich T, Kuritzkes D, Ratner L. PMID: 27128349.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    65. Ethics of ART interruption after stem-cell transplantation. Lancet HIV. 2016 Jan; 3(1):e8-10. Sugarman J, Lewin SR, Henrich TJ, Rasmussen TA. PMID: 26762996.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    66. Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV. Journal of virus eradication. 2015 Dec 1; 1:13. Hill HA, Rosenbloom RD, Kuritzkes KD, Siliciano SR, Henrich HT. .
      View in: Publisher Site   Mentions:
    67. PP 10.1 Predicting determinants of long-term HIV control with gene therapy strategies. Journal of virus eradication. 2015 Dec 1; 1:41. Hill HA, Hu HL, Hogan HL, Nowak NM, Henrich HT. .
      View in: Publisher Site   Mentions:
    68. CCR5-Δ32 Heterozygosity, HIV-1 Reservoir Size, and Lymphocyte Activation in Individuals Receiving Long-term Suppressive Antiretroviral Therapy. J Infect Dis. 2016 Mar 01; 213(5):766-70. Henrich TJ, Hanhauser E, Harrison LJ, Palmer CD, Romero-Tejeda M, Jost S, Bosch RJ, Kuritzkes DR. PMID: 26512140.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    69. Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1. Open Forum Infect Dis. 2015 Dec; 2(4):ofv123. Rosenbloom DI, Elliott O, Hill AL, Henrich TJ, Siliciano JM, Siliciano RF. PMID: 26478893.
      View in: PubMed   Mentions:
    70. Multitarget, quantitative nanoplasmonic electrical field-enhanced resonating device (NE2RD) for diagnostics. Proc Natl Acad Sci U S A. 2015 Aug 11; 112(32):E4354-63. Inci F, Filippini C, Baday M, Ozen MO, Calamak S, Durmus NG, Wang S, Hanhauser E, Hobbs KS, Juillard F, Kuang PP, Vetter ML, Carocci M, Yamamoto HS, Takagi Y, Yildiz UH, Akin D, Wesemann DR, Singhal A, Yang PL, Nibert ML, Fichorova RN, Lau DT, Henrich TJ, Kaye KM, Schachter SC, Kuritzkes DR, Steinmetz LM, Gambhir SS, Davis RW, Demirci U. PMID: 26195743.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    71. Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva. Sci Rep. 2015 Jun 05; 5:9919. Shafiee H, Kanakasabapathy MK, Juillard F, Keser M, Sadasivam M, Yuksekkaya M, Hanhauser E, Henrich TJ, Kuritzkes DR, Kaye KM, Demirci U. PMID: 26046668.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    72. HIV eradication: is cord blood the answer? Lancet HIV. 2015 Jun; 2(6):e219-20. Henrich TJ. PMID: 26423188.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    73. Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32. AIDS. 2015 May 15; 29(8):867-76. Henrich TJ, Hanhauser E, Hu Z, Stellbrink HJ, Noah C, Martin JN, Deeks SG, Kuritzkes DR, Pereyra F. PMID: 25730507.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    74. Emerging technologies for point-of-care management of HIV infection. Annu Rev Med. 2015; 66:387-405. Shafiee H, Wang S, Inci F, Toy M, Henrich TJ, Kuritzkes DR, Demirci U. PMID: 25423597.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    75. Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases. Ann Intern Med. 2014 Sep 02; 161(5):319-27. Henrich TJ, Hanhauser E, Marty FM, Sirignano MN, Keating S, Lee TH, Robles YP, Davis BT, Li JZ, Heisey A, Hill AL, Busch MP, Armand P, Soiffer RJ, Altfeld M, Kuritzkes DR. PMID: 25047577.
      View in: PubMed   Mentions: 209     Fields:    Translation:HumansCells
    76. Prevention of HIV-1 transmission with postexposure prophylaxis after inadvertent infected blood transfusion. AIDS. 2014 Jun 19; 28(10):1539-41. Al-Hajjar SH, Frayha HH, Al-Hazmi M, Batawi R, McIntosh K, Sax PE, Al-Thawadi S, Al-Jumaah S, Busch MP, Hanhauser E, Kuritzkes DR, Li JZ, Henrich TJ. PMID: 24896805.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    77. Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study. Open Forum Infect Dis. 2014 Mar; 1(1):ofu018. Hanna RF, Ward TJ, Chow DS, Lagana SM, Moreira RK, Emond JC, Weintraub JL, Prince MR, Henrich TJ, McLaren PJ, Rao SS, Lin NH, Hanhauser E, Giguel F, Gulick RM, Ribaudo H, de Bakker PI, Kuritzkes DR. PMID: 25734091; PMCID: PMC4324186.
      View in: PubMed   Mentions:
    78. Nanostructured optical photonic crystal biosensor for HIV viral load measurement. Sci Rep. 2014 Feb 28; 4:4116. Shafiee H, Lidstone EA, Jahangir M, Inci F, Hanhauser E, Henrich TJ, Kuritzkes DR, Cunningham BT, Demirci U. PMID: 24576941.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    79. HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat Med. 2014 Feb; 20(2):139-42. Buzon MJ, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, Martin-Gayo E, Leng J, Henrich TJ, Li JZ, Pereyra F, Zurakowski R, Walker BD, Rosenberg ES, Yu XG, Lichterfeld M. PMID: 24412925.
      View in: PubMed   Mentions: 203     Fields:    Translation:HumansCells
    80. Early treatment and HIV-1 reservoirs: a stitch in time? J Infect Dis. 2013 Oct 15; 208(8):1189-93. Henrich TJ, Gandhi RT. PMID: 23852126.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    81. Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis. 2013 Jun 01; 207(11):1694-702. Henrich TJ, Hu Z, Li JZ, Sciaranghella G, Busch MP, Keating SM, Gallien S, Lin NH, Giguel FF, Lavoie L, Ho VT, Armand P, Soiffer RJ, Sagar M, Lacasce AS, Kuritzkes DR. PMID: 23460751.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansCells
    82. HIV-1 entry inhibitors: recent development and clinical use. Curr Opin Virol. 2013 Feb; 3(1):51-7. Henrich TJ, Kuritzkes DR. PMID: 23290628.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    83. Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL. PLoS One. 2012; 7(11):e50065. Henrich TJ, Wood BR, Kuritzkes DR. PMID: 23166820.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    84. Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR. J Virol Methods. 2012 Dec; 186(1-2):68-72. Henrich TJ, Gallien S, Li JZ, Pereyra F, Kuritzkes DR. PMID: 22974526.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    85. HIV-2 encephalitis: case report and literature review. AIDS Patient Care STDS. 2012 Jul; 26(7):383-7. Wood BR, Klein JP, Lyons JL, Milner DA, Phillips RE, Schutten M, Folkerth RD, Ciarlini P, Henrich TJ, Johnson JA. PMID: 22694171.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    86. Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists. Antimicrob Agents Chemother. 2012 Apr; 56(4):1931-5. Henrich TJ, Lewine NR, Lee SH, Rao SS, Berro R, Gulick RM, Moore JP, Tsibris AM, Kuritzkes DR. PMID: 22252820.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    87. SHIV-162P3 infection of rhesus macaques given maraviroc gel vaginally does not involve resistant viruses. PLoS One. 2011; 6(12):e28047. Tsibris AM, Pal U, Schure AL, Veazey RS, Kunstman KJ, Henrich TJ, Klasse PJ, Wolinsky SM, Kuritzkes DR, Moore JP. PMID: 22164225.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    88. Impact of age, gender, and pregnancy on syphilis screening using the Captia Syphilis-G assay. Sex Transm Dis. 2011 Dec; 38(12):1126-30. Henrich TJ, Yawetz S. PMID: 22082723.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    89. HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug. J Virol. 2012 Jan; 86(2):1119-28. Putcharoen O, Lee SH, Henrich TJ, Hu Z, Vanichanan J, Coakley E, Greaves W, Gulick RM, Kuritzkes DR, Tsibris AM. PMID: 22090117.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    90. Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate. . 2010 Dec; 55(4):420-7. Henrich TJ, Tsibris AM, Lewine NR, Konstantinidis I, Leopold KE, Sagar M, Kuritzkes DR. PMID: 20856130.
      View in: PubMed   Mentions:
    91. Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis. 2010 Nov 15; 202(10):1478-81. Henrich TJ, Li JZ, Felsenstein D, Kotton CN, Plenge RM, Pereyra F, Marty FM, Lin NH, Grazioso P, Crochiere DM, Eggers D, Kuritzkes DR, Tsibris AM. PMID: 20936980.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    92. Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy. Clin Infect Dis. 2010 Jul 01; 51(1):93-8. Henrich TJ, Ribaudo HJ, Kuritzkes DR. PMID: 20504163.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    93. Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: A case report. Am J Dermatopathol. 2010 Apr; 32(2):175-9. Morgan EA, Henrich TJ, Jarell AD, Shieh WJ, Zaki SR, Marty FM, Thorner AR, Milner DA, Velazquez EF. PMID: 19940746.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    94. Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature. Transpl Infect Dis. 2009 Oct; 11(5):458-62. Henrich TJ, Marty FM, Milner DA, Thorner AR. PMID: 19804480.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    95. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis. 2009 Mar; 15(3):415-22. Henrich TJ, Krakower D, Bitton A, Yokoe DS. PMID: 19239754.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    96. Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211. Clin Infect Dis. 2009 Mar 01; 48(5):642-9. Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR. PMID: 19191652.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    97. Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics. J Community Health. 2008 Apr; 33(2):69-77. Henrich TJ, Lauder N, Desai MM, Sofair AN. PMID: 18046634.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    98. Geographic dynamics of viral encephalitis in Thailand. Microbes Infect. 2003 Jun; 5(7):603-11. Henrich TJ, Hutchaleelaha S, Jiwariyavej V, Barbazan P, Nitatpattana N, Yoksan S, Gonzalez JP. PMID: 12787736.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    99. Hantaan virus antibody prevalence in rodent populations of several provinces of northeastern Thailand. Trop Med Int Health. 2002 Oct; 7(10):840-5. Nitatpattana N, Henrich T, Palabodeewat S, Tangkanakul W, Poonsuksombat D, Chauvancy G, Barbazan P, Yoksan S, Gonzalez JP. PMID: 12358618.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    Timothy's Networks
    Concepts (354)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (100)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-865-g7865d7b0 on PROFILES-PWEB02.

    Copyright © The Regents of the University of California